Literature DB >> 24072766

Diagnostic accuracy and comparison of two assays for Borrelia-specific IgG and IgM antibodies: proposals for statistical evaluation methods, cut-off values and standardization.

Ram Benny Dessau1.   

Abstract

Two assays (Liaison, Diasorin; IDEIA, Oxoid) for detection of Borrelia-specific antibodies were compared. A case-control design using patients with neuroborreliosis (n = 48), laboratory defined by a positive Borrelia-specific antibody index in the spinal fluid, was available and was intended to represent the serological response of disseminated early Lyme borreliosis in general. Serum samples were obtained from 216 Danish blood donors as controls. By comparing sensitivity and specificity using pre-specified cut-off values, significant differences were found. However, using receiver operating characteristic (ROC) curves to optimize and standardize test interpretation, it was shown that testing with both IDEIA IgG and IgM was comparable to testing with Liaison IgG alone by comparing the area under the curve of the diagnostically relevant 25 % partial ROC curve (P = 0.1). When using the Liaison OspC/VlsE IgM assay, the specificity was decreased without a gain in sensitivity. This study proposes standardizing of reporting by using a control population as the reference and choosing decision thresholds guided by the risk of false-positive results at 2 and 8 %. The sensitivities for IDEIA (IgG and IgM combined) were 85 and 95 % and for the Liaison (VlsE IgG) method were 67 and 96 %, respectively. Methods for test evaluation, test interpretation and statistical testing are presented and discussed. In conclusion, Liaison VlsE IgG alone and IDEIA IgG/IgM combined showed a high and comparable discriminatory ability to distinguish serum samples from patients with neuroborreliosis from blood donor controls. However, cut-off values should be adjusted for a proper comparison.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24072766     DOI: 10.1099/jmm.0.061275-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  10 in total

1.  A Multiplexed Serologic Test for Diagnosis of Lyme Disease for Point-of-Care Use.

Authors:  Siddarth Arumugam; Samiksha Nayak; Taylor Williams; Francesco Serra di Santa Maria; Mariana Soares Guedes; Rodrigo Cotrim Chaves; Vincent Linder; Adriana R Marques; Elizabeth J Horn; Susan J Wong; Samuel K Sia; Maria Gomes-Solecki
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

2.  The Performance of Nine Commercial Serological Screening Assays for the Diagnosis of Lyme Borreliosis: a Multicenter Modified Two-Gate Design Study.

Authors:  B J A Hoeve-Bakker; Mark Jonker; Afke H Brandenburg; P Martijn den Reijer; Foekje F Stelma; Alje P van Dam; Tamara van Gorkom; Karen Kerkhof; Steven F T Thijsen; Kristin Kremer
Journal:  Microbiol Spectr       Date:  2022-03-17

3.  Diagnostic Performance of the Novel BioPlex Lyme Serological Assays in European Patients with Lyme Disease.

Authors:  M E (Ewoud) Baarsma; Jeanine Ursinus; Hans L Zaaijer; Herman Kuiper; Joppe W Hovius
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

Review 4.  A 60-Year-Old Swiss Woman Presenting with Migratory Radicular Pain Diagnosed with Lyme Disease by Western Blot.

Authors:  Gisela Marcelino; João Cerveira; André Teychené; Armand Eichenberger
Journal:  Am J Case Rep       Date:  2022-04-10

Review 5.  The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis.

Authors:  M M G Leeflang; C W Ang; J Berkhout; H A Bijlmer; W Van Bortel; A H Brandenburg; N D Van Burgel; A P Van Dam; R B Dessau; V Fingerle; J W R Hovius; B Jaulhac; B Meijer; W Van Pelt; J F P Schellekens; R Spijker; F F Stelma; G Stanek; F Verduyn-Lunel; H Zeller; H Sprong
Journal:  BMC Infect Dis       Date:  2016-03-25       Impact factor: 3.090

6.  Commercial test kits for detection of Lyme borreliosis: a meta-analysis of test accuracy.

Authors:  Michael J Cook; Basant K Puri
Journal:  Int J Gen Med       Date:  2016-11-18

7.  Modified interpretation criteria significantly improve performance of commercially available confirmatory assays for the serodiagnosis of Lyme borreliosis: a case-control study with clinically defined serum samples.

Authors:  Ulrike Hauser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-02-04       Impact factor: 3.267

8.  Antibiotic Use and Long-Term Outcome in Patients with Tick-Borne Encephalitis and Co-Infection with Borrelia Burgdorferi Sensu Lato in Central Europe. A Retrospective Cohort Study.

Authors:  Maša Velušček; Rok Blagus; Tjaša Cerar Kišek; Eva Ružić-Sabljić; Tatjana Avšič-Županc; Fajko F Bajrović; Daša Stupica
Journal:  J Clin Med       Date:  2019-10-20       Impact factor: 4.241

9.  Diagnostic parameters of modified two-tier testing in European patients with early Lyme disease.

Authors:  M E Baarsma; Jfp Schellekens; B C Meijer; A H Brandenburg; T Souilljee; A Hofhuis; J W Hovius; A P van Dam
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-07-06       Impact factor: 3.267

10.  Application of Bayesian decision-making to laboratory testing for Lyme disease and comparison with testing for HIV.

Authors:  Michael J Cook; Basant K Puri
Journal:  Int J Gen Med       Date:  2017-04-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.